5th Apr 2022 11:50
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Says its Steriwave photodisinfection laser technology was 99.99% effective at inactivating Sars-CoV-2, the virus that causes Covid-19, in mammalian cell culture. This inhibits infectivity, the firm adds. Citing a new study published in the Journal of Photochemical & Photobiological Sciences, the study "reconfirmed that a single dose of photodisinfection is capable of destroying both the Sars-CoV-2 viral spike and viral genome, reducing viral load to below detection limit within five minutes," Ondine says.
"The study was led by a team of researchers from the University of Coimbra, Portugal, and was conducted at leading European research centre, the University of Coimbra Hospital Centre (CHUC)," the company explains.
Current stock price: 46.00 pence, down 2.1% on Tuesday
12-month change: down 21%
By Tom Budszus; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Ondine Biomed